AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Vanda Pharmaceuticals Inc.

$3.79 -$4.46 (-54.06%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$4.05
Day Range
$3.74$4.11
Year Range
$3.74$9.94
Market Cap
229.18M
AVG Volume
991.27K
Trailing/Forward PE
-0.82/-
PEG ratio
0.67
Dividend Yield
-
Next Earnings Date
2027-02-10
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0100M200M300M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
VNDA Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q3229.28M
26 Q2215.72M
26 Q1217.78M
25 Q4216.1M
25 Q3212.07M
25 Q2203.47M
25 Q1201.35M
24 Q4198.77M
24 Q3190.86M
24 Q2182.02M
Net Income (USD) · TTM
-300M-200M-100M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
VNDA Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q3-274.83M
26 Q2-274.85M
26 Q1-239.55M
25 Q4-220.47M
25 Q3-84.2M
25 Q2-66.94M
25 Q1-44.25M
24 Q4-18.9M
24 Q3-16.39M
24 Q2-10.93M
Operating Income (USD) · TTM
-200M-150M-100M-50M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
VNDA Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q3-177.91M
26 Q2-185.67M
26 Q1-160.36M
25 Q4-154.69M
25 Q3-124.61M
25 Q2-104.33M
25 Q1-75.97M
24 Q4-40.66M
24 Q3-37.48M
24 Q2-32.47M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: VNDA

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 10 Feb 2027.

Vanda Pharmaceuticals Inc.
VNDA
Stockpicker

Video analysis: VNDA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: VNDA

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.